SMSara G. Murray

Sara G. Murray

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sara G. Murray has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Gabriela Schmajuk

    Department of Medicine, University of California, San Francisco, California, USA

    4 shared publications
  • Jinoos Yazdany

    Department of Medicine, University of California, San Francisco, California, USA

    4 shared publications
  • Laura Trupin

    Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

    3 shared publications
  • Edward H. Yelin

    University of California San Francisco and Phillip R. Lee Institute for Health Policy Studies San Francisco California

    2 shared publications
  • Patricia P. Katz

    University of California San Francisco and Phillip R. Lee Institute for Health Policy Studies San Francisco California

    2 shared publications
  • Alvin Rajkomar

    Division of Hospital Medicine, Department of Medicine, University of California, San Francisco

    1 shared publication

Latest Publications

  • Open Access

    Patient Safety Risks from AI Scribes: Signals from End-User Feedback

    by Jessica Dai, Anwen Huang, Catherine Nasrallah, Rhiannon Croci, Hossein Soleimani, Sarah J. Pollet, Julia Adler-Milstein, Sara G. Murray, Jinoos Yazdany, Irene Y. Chen

    AI scribes are transforming clinical documentation at scale. However, their real-world performance remains understudied, especially regarding their impacts on patient safety. To this end, we initiate a mixed-methods study of patient safety issues raised in feedback submitted by AI scribe users (healthcare providers) in a large U.S. hospital system. Both quantitative and qualitative analysis suggest that AI scribes may induce various patient safety risks due to errors in transcription, most significantly regarding medication and treatment; however, further study is needed to contextualize the absolute degree of risk.


  • Open Access

    Establishing priorities for implementation of large language models in pathology and laboratory medicine

    by Simone Arvisais-Anhalt, Steven L. Gonias, Sara G. Murray


  • Automating Measurement of Trainee Work Hours

    by Hossein Soleimani, Julia Adler-Milstein, Russell J Cucina, Sara G Murray

    BACKGROUND: Medical training programs across the country are bound to a set of work hour regulations, generally monitored via self-report. OBJECTIVE: We developed a computational method to automate measurement of intern and resident work hours, which we validated against self-report. DESIGN, SETTING, AND PARTICIPANTS: We included all electronic health record (EHR) access log data between July 1, 2018, and June 30, 2019, for trainees enrolled in the internal medicine training program. We inferred the duration of continuous in-hospital work hours by linking EHR sessions that occurred within 5 hours as “on-campus” work and further accounted for “out-of-hospital” work which might be taking place at home. MAIN OUTCOMES AND MEASURES: We compared daily work hours estimated through the computational method with self-report and calculated the mean absolute error between the two groups. We used the computational method to estimate average weekly work hours across the rotation and the percentage of rotations where average work hours exceed the 80-hour workweek. RESULTS: The mean absolute error between self-reported and EHR-derived daily work hours for first- (PGY-1), second- (PGY-2), and third- (PGY-3) year trainees were 1.27, 1.51, and 1.51 hours, respectively. Using this computational method, we estimated average (SD) weekly work hours of 57.0 (21.7), 69.9 (12.2), and 64.1 (16.3) for PGY-1, PGY-2, and PGY-3 residents. CONCLUSION: EHR log data can be used to accurately approximate self-report of work hours, accounting for both in-hospital and out-of-hospital work. Automation will reduce trainees’ clerical work, improve consistency and comparability of data, and provide more complete and timely data that training programs need.


  • Open Access

    Automated and flexible identification of complex disease: building a model for systemic lupus erythematosus using noisy labeling

    by Sara G Murray, Anand Avati, Gabriela Schmajuk, Jinoos Yazdany

    Accurate and efficient identification of complex chronic conditions in the electronic health record (EHR) is an important but challenging task that has historically relied on tedious clinician review and oversimplification of the disease. Here we adapt methods that allow for automated “noisy labeling” of positive and negative controls to create a “silver standard” for machine learning to automate identification of systemic lupus erythematosus (SLE). Our final model, which includes both structured data as well as text processing of clinical notes, outperformed all existing algorithms for SLE (AUC 0.97). In addition, we demonstrate how the probabilistic outputs of this model can be adapted to various clinical needs, selecting high thresholds when specificity is the priority and lower thresholds when a more inclusive patient population is desired. Deploying a similar methodology to other complex diseases has the potential to dramatically simplify the landscape of population identification in the EHR. MeSH terms: Electronic Health Records, Machine Learning, Lupus Erythematosus, Phenotype, Algorithms


  • Open Access

    Using Spatial and Temporal Mapping to Identify Nosocomial Disease Transmission of Clostridium difficile

    by Sara G. Murray, Joanne W. L. Yim, Rhiannon Croci, Alvin Rajkomar, Gabriela Schmajuk, Raman Khanna, Russell J. Cucina

    Hospital-acquired Clostridium difficile infection (CDI) is associated with significant morbidity and mortality.1 While risk factors like antibiotic exposure modulate susceptibility, infection control efforts aimed at reducing contact with infectious spores are critical to prevent nosocomial transmission.2-5 During hospitalization, patients visit many procedural and diagnostic common areas, presenting opportunities for contact with contaminated surfaces. However, these potential exposures are not typically captured in analyses evaluating disease transmission.6 Electronic health record (EHR) data allow us to track patients in time and space, but these data are not typically leveraged for infection control quality improvement efforts. We evaluated whether using a room within 24 hours of a patient with CDI was associated with increased risk of CDI in specific areas across our hospital.


  • Open Access

    National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia

    by Sara G Murray, Gabriela Schmajuk, Laura Trupin, Lianne Gensler, Patricia P Katz, Edward H Yelin, Stuart A Gansky, Jinoos Yazdany

    Infection is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). Therapeutic practices have evolved over the past 15 years, but effects on infectious complications of SLE are unknown. We evaluated trends in hospitalizations for severe and opportunistic infections in a population-based SLE study. Data derive from the 2000 to 2011 United States National Inpatient Sample, including individuals who met a validated administrative definition of SLE. Primary outcomes were diagnoses of bacteremia, pneumonia, opportunistic fungal infection, herpes zoster, cytomegalovirus, or pneumocystis pneumonia (PCP). We used Poisson regression to determine whether infection rates were changing in SLE hospitalizations and used predictive marginals to generate annual adjusted rates of specific infections. We identified 361,337 SLE hospitalizations from 2000 to 2011 meeting study inclusion criteria. Compared to non-SLE hospitalizations, SLE patients were younger (51 vs. 62 years), predominantly female (89% vs. 54%), and more likely to be racial/ethnic minorities. SLE diagnosis was significantly associated with all measured severe and opportunistic infections. From 2000 to 2011, adjusted SLE hospitalization rates for herpes zoster increased more than non-SLE rates: 54 to 79 per 10,000 SLE hospitalizations compared with 24 to 29 per 10,000 non-SLE hospitalizations. Conversely, SLE hospitalizations for PCP disproportionately decreased: 5.1 to 2.5 per 10,000 SLE hospitalizations compared with 0.9 to 1.3 per 10,000 non-SLE hospitalizations. Among patients with SLE, herpes zoster hospitalizations are rising while PCP hospitalizations are declining. These trends likely reflect evolving SLE treatment strategies. Further research is needed to identify patients at greatest risk for infectious complications.


  • A Breakthrough Diagnosis

    by Sara G Murray, Robert M Wachter, Kerry C Cho, Gurpreet Dhaliwal

    A 19-year-old woman with multiple sclerosis presented with altered mental status, respiratory distress, and abdominal distention after a flight from Jordan to the United States.


  • Open Access

    A Population‐Based Study of Infection‐Related Hospital Mortality in Patients With Dermatomyositis/Polymyositis

    by Sara G. Murray, Gabriela Schmajuk, Laura Trupin, Erica Lawson, Matthew Cascino, Jennifer Barton, Mary Margaretten, Patricia P. Katz, Edward H. Yelin, Jinoos Yazdany

    Objective: Dermatomyositis (DM) and polymyositis (PM) are debilitating inflammatory myopathies associated with significant mortality. We evaluated the relative contribution of infection to hospital mortality in a large population‐based study of individuals with PM/DM.Methods: Data derive from the 2007 to 2011 Healthcare Cost and Utilization Project National Inpatient Samples and include all hospital discharges that met a validated administrative definition of PM/DM. The primary outcome was hospital mortality. Variables for infections and comorbidities were generated from discharge diagnoses using validated administrative definitions. Logistic regression was used to investigate the relationship between infection and mortality in individuals with PM/DM, adjusting for sociodemographics, utilization variables, and comorbidities. Relative risks (RRs) were calculated to compare the overall prevalence of specific infections and associated mortality in PM/DM hospitalizations with those seen in the general hospitalized population.Results: A total of 15,407 hospitalizations with PM/DM met inclusion criteria for this study and inpatient mortality was 4.5% (700 deaths). In adjusted logistic regression analyses, infection (odds ratio [OR] 3.4, 95% confidence interval [95% CI] 2.9–4.0) was the strongest predictor of hospital mortality among individuals with PM/DM. Bacterial infection (OR 3.5, 95% CI 3.0–4.1), comprised primarily of pneumonia and bacteremia, and opportunistic fungal infections (OR 2.5, 95% CI 1.5–4.0) were independently associated with hospital mortality. The overall burden of infection in hospitalizations with PM/DM was significantly increased in comparison with the general hospitalized population (RR 1.5, 95% CI 1.4–1.6).Conclusion: Among hospitalized individuals with PM/DM, infection is the leading cause of mortality. Strategies to mitigate infection risk in both the clinic and hospital settings should be evaluated to improve disease outcomes.


  • Open Access

    Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus

    by Sara G. Murray, Jinoos Yazdany, Rachel Kaiser, Lindsey A. Criswell, Laura Trupin, Edward H. Yelin, Patricia P. Katz, Laura J. Julian

    Objective: Cognitive dysfunction and cardiovascular disease are common and debilitating manifestations of systemic lupus erythematosus (SLE). In this study, we evaluated the relationship between cardiovascular events, traditional cardiovascular risk factors, and SLE‐specific risk factors as predictors of cognitive dysfunction in a large cohort of participants with SLE.Methods: Subjects included 694 participants from the Lupus Outcomes Study (LOS), a longitudinal study of SLE outcomes based on an annual telephone survey querying demographic and clinical variables. The Hopkins Verbal Learning Test‐Revised and the Controlled Oral Word Association Test were administered to assess cognitive function. Multiple logistic regression was used to identify cardiovascular events (myocardial infarction, stroke), traditional cardiovascular risk factors (hypertension, hyperlipidemia, diabetes mellitus, obesity, smoking), and SLE‐specific risk factors (antiphospholipid antibodies [aPL], disease activity, disease duration) associated with cognitive impairment in year 7 of the LOS.Results: The prevalence of cognitive impairment as measured by verbal memory and verbal fluency metrics was 15%. In adjusted multiple logistic regression analyses, aPL (odds ratio [OR] 2.10, 95% confidence interval [95% CI] 1.3–3.41), hypertension (OR 2.06, 95% CI 1.19–3.56), and a history of stroke (OR 2.27, 95% CI 1.16–4.43) were significantly associated with cognitive dysfunction. In additional analyses evaluating the association between these predictors and severity of cognitive impairment, stroke was significantly more prevalent in participants with severe impairment when compared to those with mild or moderate impairment (P = 0.036).Conclusion: These results suggest that the presence of aPL, hypertension, and stroke are key variables associated with cognitive impairment, which may aid in identification of patients at greatest risk.